bioAffinity Technologies (BIAF) Other Working Capital Changes (2021 - 2026)
bioAffinity Technologies has reported Other Working Capital Changes over the past 5 years, most recently at -$40002.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 520.57% to -$40002.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$15555.0 through Mar 2026, down 120.67% year-over-year, with the annual reading at $18001.0 for FY2025, 82.95% down from the prior year.
- Other Working Capital Changes was -$40002.0 for Q1 2026 at bioAffinity Technologies, down from -$12330.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $530481.0 in Q3 2022 and troughed at -$89847.0 in Q1 2023.
- The 5-year median for Other Working Capital Changes is -$6446.0 (2025), against an average of $35847.3.
- Year-over-year, Other Working Capital Changes plummeted 706.31% in 2023 and then soared 2300.46% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$9424.0 in 2022, then soared by 44.91% to -$5192.0 in 2023, then soared by 2300.46% to $114248.0 in 2024, then plummeted by 110.79% to -$12330.0 in 2025, then plummeted by 224.43% to -$40002.0 in 2026.
- Per Business Quant, the three most recent readings for BIAF's Other Working Capital Changes are -$40002.0 (Q1 2026), -$12330.0 (Q4 2025), and $60037.0 (Q3 2025).